Concourse Financial Group Securities, Inc. Biotechnology

Concourse Financial Group Securities, Inc.

$1.67 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ANTX An2 Therapeutics, Inc.	$24.6M	$0 0.0% of portfolio	0	Q4 2024 New
AVXL Anavex Life Sciences Corp.	$687M	$0 0.0% of portfolio	0	Q4 2024 New
ANEB Anebulo Pharmaceuticals, Inc.	$24.4M	$0 0.0% of portfolio	0	Q4 2024 New
ANIX Anixa Biosciences Inc	$81.3M	$0 0.0% of portfolio	0	Q4 2024 New
ANNX Annexon, Inc.	$72.9M	$0 0.0% of portfolio	0	Q4 2024 New
ANVS Annovis Bio, Inc.	$10.1M	$0 0.0% of portfolio	0	Q4 2024 New
APLS Apellis Pharmaceuticals, Inc.	$2.12B	$0 0.0% of portfolio	0	Q4 2024 New
APLT Applied Therapeutics Inc.	$15.8M	$0 0.0% of portfolio	0	Q4 2024 New
APRE Aprea Therapeutics, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
APM Aptorum Group LTD	$11.1M	$0 0.0% of portfolio	0	Q4 2024 New
ABUS Arbutus Biopharma Corp	$492M	$0 0.0% of portfolio	0	Q4 2024 New
ACLX Arcellx, Inc.	$2.66B	$0 0.0% of portfolio	0	Q4 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$271M	$0 0.0% of portfolio	0	Q4 2024 New
RCUS Arcus Biosciences, Inc.	$554M	$0 0.0% of portfolio	0	Q4 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$779M	$0 0.0% of portfolio	0	Q4 2024 New
ARDX Ardelyx, Inc.	$707M	$0 0.0% of portfolio	0	Q4 2024 New
ARGX Argenx Se	$33.5B	$0 0.0% of portfolio	1	Q1 2024 New
ARMP Armata Pharmaceuticals, Inc.	$41.9M	$0 0.0% of portfolio	0	Q4 2024 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.31B	$0 0.0% of portfolio	0	Q4 2024 New
ARVN Arvinas, Inc.	$394M	$0 0.0% of portfolio	0	Q4 2024 New
ASND Ascendis Pharma A/S	$8.68B	$0 0.0% of portfolio	0	Q4 2024 New
ASLN Aslan Pharmaceuticals LTD	$41.8M	$0 0.0% of portfolio	0	Q4 2024 New
ATXS Astria Therapeutics, Inc.	$65.9M	$0 0.0% of portfolio	0	Q4 2024 New
ATAI Atai Life Sciences N.V.	$229M	$0 0.0% of portfolio	0	Q4 2024 New
AVIR Atea Pharmaceuticals, Inc.	$245M	$0 0.0% of portfolio	0	Q4 2024 New
ATHA Athira Pharma, Inc.	$9.83M	$0 0.0% of portfolio	0	Q4 2024 New
ATOS Atossa Therapeutics, Inc.	$79.8M	$0 0.0% of portfolio	0	Q4 2024 New
LIFE A Tyr Pharma Inc	$53.2M	$0 0.0% of portfolio	0	Q4 2024 New
AURA Aura Biosciences, Inc.	$160M	$0 0.0% of portfolio	0	Q4 2024 New
AUPH Aurinia Pharmaceuticals Inc.	$1.1B	$0 0.0% of portfolio	0	Q4 2024 New
AUTL Autolus Therapeutics PLC	$122M	$0 0.0% of portfolio	0	Q4 2024 New
AVEO Aveo Pharmaceuticals, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
CDMO Avid Bioservices, Inc.	$776M	$0 0.0% of portfolio	0	Q4 2024 New
RNA Avidity Biosciences, Inc.	$1.4B	$0 0.0% of portfolio	0	Q4 2024 New
AXSM Axsome Therapeutics, Inc.	$4.44B	$0 0.0% of portfolio	0	Q4 2024 New
AYLA Ayala Pharmaceuticals, Inc.	$0	$0 0.0% of portfolio	0	Q4 2024 New
BEAM Beam Therapeutics Inc.	$1.2B	$0 0.0% of portfolio	0	Q4 2024 New
BGNE Bei Gene, Ltd.	$23.5B	$0 0.0% of portfolio	0	Q4 2024 New
BLTE Belite Bio, Inc	$1.48B	$0 0.0% of portfolio	0	Q4 2024 New
BYSI Beyond Spring Inc.	$45.5M	$0 0.0% of portfolio	0	Q4 2024 New
BCYC Bicycle Therapeutics PLC	$210M	$0 0.0% of portfolio	0	Q4 2024 New
BCAB Bio Atla, Inc.	$11.6M	$0 0.0% of portfolio	0	Q4 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.31B	$0 0.0% of portfolio	0	Q4 2024 New
BLRX Bio Line Rx Ltd.	$178M	$0 0.0% of portfolio	0	Q4 2024 New
BMRN Biomarin Pharmaceutical Inc	$11.1B	$0 0.0% of portfolio	15	Q3 2024 Reduced 70.59%
BMEA Biomea Fusion, Inc.	$47.5M	$0 0.0% of portfolio	0	Q4 2024 New
BNTX Bio N Tech Se	$24.8B	$0 0.0% of portfolio	0	Q4 2024 New
BPTS Biophytis Sa	$115M	$0 0.0% of portfolio	0	Q4 2024 New
BRTX Bio Restorative Therapies, Inc.	$6.57M	$0 0.0% of portfolio	0	Q4 2024 New
BTAI Bio Xcel Therapeutics, Inc.	$53.8M	$0 0.0% of portfolio	0	Q4 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.